CAS RN: 1694-31-1
tert-Butyl Acetoacetate
Product Availability
Choose a grade to view its available package options.
4 package records 4 with current stock 1 grade group
Grade
≥95% (4)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250324
100ml
In stock
Inquiry
Batchno.20251114
2.5L
In stock
Inquiry
Batchno.20250728
25ml
In stock
Inquiry
Batchno.20251224
500ml
In stock
Inquiry
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
Pack sizes on record: 25g, 100g, 500g, 1000g
Available purity: ≥95%
Inventory rows with stock: 4
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1694-31-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
5
In Stock
Hong Kong
Inquiry
100g
≥95%
5
In Stock
Shanghai
Inquiry
500g
≥95%
5
In Stock
Shenzhen
Inquiry
1000g
≥95%
5
In Stock
Beijing
Inquiry
1694-31-1 / tert-butyl 3-oxobutanoate
Standard CAS: 1694-31-1
Multi CAS: No
Basic Information
copy
CAS
1694-31-1 copy
Multi CAS
No copy
Molecular Formula
C8H14O3 copy
Molecular Weight
158.190000 copy
Exact Mass
158.094294 copy
SMILES
CC(=O)CC(=O)OC(C)(C)C copy
InChI
InChI=1S/C8H14O3/c1-6(9)5-7(10)11-8(2,3)4/h5H2,1-4H3 copy
InChIKey
JKUYRAMKJLMYLO-UHFFFAOYSA-N copy
Physical Properties
copy
Physical Description
Colorless odorless liquid copy
State
Liquid copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Fraction Csp3
0.75 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
Molar refractivity
41.14 copy
TPSA
43.37 copy
LogP / Solubility
WLOGP
1.31 copy
MLOGP
1.15 copy
XLogP3
1 copy
Consensus LogP
1.15 copy
Log S (ESOL)
-1.51 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.8 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2.01 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.76 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 49 of 51 companies (only 3.9% companies provided GHS information). For more detailed information, please visit ECHA C&L website. copy